REGEN
Get REGENGet Now
LibraryToolsNotesBlogFAQ

Tesamorelin + Ipamorelin Blend Side Effects and Safety

Reported Tesamorelin + Ipamorelin Blend side effects, contraindications, and safety signals.

RE
Compiled from published research · Last updated 2026-08-18T00:00:00.000Z

Combined Component Risk Profile

Tesamorelin's FDA label documents injection-site reactions, joint pain/arthralgia, and peripheral edema as the most common effects, plus a mild reduction in glucose tolerance in some patients — worth monitoring via fasting glucose/HbA1c. Ipamorelin's ghrelin-receptor mechanism is generally considered the most selective (fewest off-target effects) among GH secretagogues. Active malignancy and pregnancy are contraindicated given the GH/IGF-1 axis stimulation shared by both components.

Contraindications

  • active malignancy
  • pregnancy
All Tesamorelin + Ipamorelin Blend sections

hCG (Human Chorionic Gonadotropin)

growth & hormonesSgrade

An FDA-approved hormone that mimics LH, restoring the body's own testosterone and sperm production — the label dates to 1962.

CJC-1295 (no-DAC) + Ipamorelin Blend

growth & GHCgrade

A single-vial blend pairing short-acting CJC-1295 (no-DAC) with Ipamorelin for a clean, physiological GH pulse in one shot.

Ipamorelin

growth & GHCgrade

A selective GH secretagogue (ghrelin mimetic) that raises growth hormone with minimal effect on cortisol or appetite.

Put the whole protocol
in one place.

Download nowGet Now